Eligibility, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Diabetes ComplicationsPrimary· Baseline and week 520
Diabetic Complications: diabetic retinopathy,diabetic nephropathy,cerebral infarction,coronary artery disease The diagnosis of coronary artery disease is based on a comprehensive assessment of the degree of coronary artery stenosis and evidence of myocardial ischemia, taking into account risk factors and clinical symptoms, and exclusion of other similar diseases.
The diagnostic criteria for diabetic nephropathy are history of diabetes: clear and long history of diabetes, Urine protein test:Urinary microalbumin excretion rate (UACR) is a key indicator for early diagnosis, with a normal value o
Group
Value
95% CI
Coronary Artery Disease
10263
Cerebral Infarction
97864
Diabetic Retinopathy
59029
Diabetic Nephropathy
69822
Coronary Artery Disease
386720
Cerebral Infarction
299119
Diabetic Retinopathy
337954
Diabetic Nephropathy
327161
Glycemic ControlSecondary· baseline and week 520
Average level of glucose: including Glycated Hemoglobin (HbA1c), the mean of fasting glucose(FG) Glucose Variability: including standard deviation, coefficient of variation of HbA1c and FG.
Group
Value
95% CI
Mean Fasting Blood Glucose Level of the Population
8.7
± 3.36
DeathSecondary· baseline and week 520
death from all cause, diabetes complications, and cancer.
Group
Value
95% CI
All Cause
21669
All Cause
375314
Sponsor's own description
The goal of this observational study is to reveal the natural history of diabetes and the occurrence and development patterns of its complications, to evaluate the effectiveness of diabetes interventions, and to assess the health and medical burdens caused by diabetes in Tianjin, based on the medical records and health big data in Tianjin and correspondingly constructed diabetes-specific cohort.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07533513 — Effects and Mechanisms of Dietary Carbohydrate Intake and Quality on Glucose and Lipid Metabolism
· NA
· not yet recruiting
NCT07457827 — Effect of Low-Carbohydrate Versus Balanced Diets on Anthropometric Blood Pressure, ApoB, and hsCRP in Healthy Adults
· NA
· not yet recruiting
NCT07388589 — Soluble and Osmotic Fibre (SOLOS) Diet for Constipation
· not yet recruiting
NCT07289672 — Food Limitations In Crohn's Disease and Ulcerative coliTis
· NA
· not yet recruiting
NCT07262112 — Efficacy of Resistance Exercise and an Anti-Inflammatory Diet on Pain, Disease Activity, Functional Status, and Quality
· NA
· not yet recruiting
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
· NA
· recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I
· NA
· recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit
· NA
· recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients
· NA
· recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens
· NA
· recruiting
Other Tianjin Medical University trials
Trials by the same sponsor.
NCT07393685 — Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD
· not yet recruiting
NCT07306598 — [18F]NIDF PET Imaging in Tau-related Diseases
· recruiting
NCT07232459 — [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
· recruiting
NCT06949670 — Alpha-Synuclein PET/CT in Various α-Syn-Related Disease
· recruiting
NCT06628531 — ALI & Pulmonary HA Deposition After SAH
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tianjin Medical University
Last refreshed: 25 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06913153.